Information:
Error:
ID
34154
Description
Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32; ODM derived from: https://clinicaltrials.gov/show/NCT01286233
Link
https://clinicaltrials.gov/show/NCT01286233
Keywords
Versions (1)
- 1/14/19 1/14/19 -
Copyright Holder
see on clinicaltrials.gov
Uploaded on
January 14, 2019
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Cancer NCT01286233
Eligibility Breast Cancer NCT01286233
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT01286233
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
ID.1
Item
the patient must have consented to participate and must have signed and dated an appropriate irb-approved consent form that conforms to federal and institutional guidelines for the ma.32.f study before being enrolled.
boolean
ID.2
Item
the patient must be female.
boolean
ID.3
Item
the patient must reside in the united states or canada.
boolean
ID.4
Item
the patient must be english-speaking.
boolean
ID.5
Item
the patient must be eligible for randomization in the ma.32 treatment trial. (participation in the ma.32 qol study is permitted but not required.)
boolean
ID.6
Item
the patient must not have started taking ma.32 study therapy.
boolean
ID.7
Item
the patient must have completed primary breast radiation therapy at least two weeks prior to enrollment in ma.32.f.
boolean
ID.8
Item
ma.32 study therapy has been initiated.
boolean
ID.9
Item
currently receiving radiation therapy or additional radiation therapy is planned for initiation after starting ma.32 study therapy.
boolean